| 摘要 |
Liposomes encapsulating doxorubicin, which contain, incorporated into them, a protector compound of general formula A or B, in order to reduce the toxicity of the drug when it is administered in intravenous form, and in which formulas R1 and R2, are the same or different, independently represented by HO-, CH3O- or CF3CH2O- <CHEM> |
